This site is intended for Healthcare professionals only.

Zydus Cadila gets USFDA nod for sclerosis drug

Zydus Cadila gets USFDA nod for sclerosis drug

New Delhi: Drug firm Zydus Cadila said it has received tentative nod from the US health regulator to market Fingolimod capsules used for treatment of multiple sclerosis.

“The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market Fingolimod capsules 0.5 mg,” Cadila Healthcare said in a filing to BSE.

The drug will be produced at the groups formulations manufacturing facility at pharma SEZ in Ahmedabad, it added.

The product is mainly used for treating multiple sclerosis, Cadila said.

The group now has over 120 approvals and has so far filed more than 300 Abbreviated New Drug Applications (ANDAs), it added.

Source: PTI
0 comment(s) on Zydus Cadila gets USFDA nod for sclerosis drug

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted